Investors & Media Contact Us Linkedin Twitter Who We Are Focus Areas Pipeline Patients Careers People with cancer can’t wait. Let’s go. The full potential of targeted oncology is waiting to be unlocked. That’s why we relentlessly pursue every possibility to create new cancer breakthroughs and power our approach with people who think hard, care hard and act with urgency. At SpringWorks, we bring tenacity to work every day because patients need answers now. SEE HOW WE WORK Recent News NOVEMBER 23, 2021 SpringWorks Therapeutics to Participate in the 4th Annual Evercore ISI HealthCONx Conference Read More NOVEMBER 4, 2021 SpringWorks Therapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights Read More OCTOBER 27, 2021 SpringWorks Therapeutics Announces the Initiation of an Expanded Phase 2 Cohort and Addition of New Sub-Studies to Existing Clinical Collaboration with GlaxoSmithKline Evaluating Nirogacestat in Combination with BLENREP in Patients with Relapsed or Refractory Multiple Myeloma Read More View All Linkedin Twitter Who We Are Leadership & Board Mission & Values Partners & Collaborators Focus Areas Rare Oncology BCMA Combinations in Multiple Myeloma Biomarker-Defined Metastatic Solid Tumors Pipeline Nirogacestat Mirdametinib Clinical Trials Investigator-Initiated Research Careers View Opportunities Patients Desmoid Tumors NF1-PN Expanded Access Contact Investors & Media Press Releases Events & Presentations Corporate Governance Financial Information Stock Information Investor Resources © 2021 SpringWorks Therapeutics. All rights reserved. Privacy Policy Terms of Use By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies